COMMUNIQUÉS West-GlobeNewswire

Mustang Bio Announces Appointment of Brian Achenbach as Vice President of Finance and Corporate Controller

14/11/2017 - 14:30

NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech, Inc. (NASDAQ: FBIO ) company focused on the development of novel immunotherapies based on proprietary [...]

Alpha II Announces Launch of Easy Coder Web-based Application

14/11/2017 - 14:30

TALLAHASSEE, Fla., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Alpha II, LLC , a leading developer of software-as-a-service (SaaS) solutions that support healthcare reimbursement, today announced the transition of CodingSystem to [...]

Representatives of Fulgent Genetics to Participate in the Piper Jaffray 29th Annual Healthcare Conference

14/11/2017 - 14:30

TEMPLE CITY, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT ) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming Hsieh and its Chief [...]

Mustang Bio Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

14/11/2017 - 14:30

NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]

Celsion Corporation Reports Third Quarter 2017 Financial Results and Provides Business Update

14/11/2017 - 14:00

Recent Minimally Dilutive Financings Substantially Strengthen Balance Sheet and Provide Runway to Significant Clinical Milestones for ThermoDox ® and GEN-1 Clinical Programs Company to Hold Conference Call on Tuesday, [...]

Rhythm Pharmaceuticals Reports Third Quarter 2017 Financial Results

14/11/2017 - 14:00

- Successfully Completed Upsized Initial Public Offering Raising $137.8 Million in Gross Proceeds - - Presented Preliminary Data from Phase 2 Clinical Trial of Setmelanotide in Bardet-Biedl Syndrome (BBS) at ObesityWeek [...]

RavenQuest Announces Formal Agreement With Fort McMurray #468 First Nation

14/11/2017 - 14:00

VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) is pleased to announce it has entered into an agreement with Fort McMurray #468 First [...]

Albireo Reports Third Quarter 2017 Financial Results

14/11/2017 - 14:00

— Executing towards planned A4250 Phase 3 PFIC trial — — Decision on potential approval of elobixibat in Japan expected in the first half of 2018 — BOSTON, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ [...]

Gallup and Sharecare Release New Research on the Cost of Diabetes to U.S. Communities and Employers

14/11/2017 - 14:00

WASHINGTON and ATLANTA, Nov. 14, 2017 (GLOBE NEWSWIRE) -- World-leading analytics and advice firm, Gallup, and Sharecare, the digital health company helping people manage all their health in one place, have released new [...]

Cannabix Technologies makes “50 B.C. Innovations to Watch List” with Marijuana Breathalyzer, Added to CSE25 Index

14/11/2017 - 14:00

VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company or Cannabix”), developer of the Cannabix Marijuana Breathalyzer for law enforcement and [...]

Mateon Provides Corporate Update and Reports Third Quarter 2017 Financial Results

14/11/2017 - 14:00

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today [...]

PositiveID Reports Third Quarter 2017 Results; Revenues increase 38% Year over Year

14/11/2017 - 14:00

DELRAY BEACH, Fla., Nov. 14, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today its financial results for the quarter ended [...]

EyeGate Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

14/11/2017 - 14:00

WALTHAM, Mass., Nov. 14, 2017 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies [...]

Poseida Therapeutics Presents on the Development of Allogeneic and Autologous BCMA-Specific CAR-T Therapies at Precision: Blood Cancer Summit

14/11/2017 - 14:00

SAN DIEGO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, will participate [...]

Actinium Pharmaceuticals Launches the AWE Program aka Actinium Warhead Enabling Program to Enable Collaborations Based on Its Actinium-225 Technology Platform

14/11/2017 - 14:00

- AWE Program launched post successful demonstration of Actinium’s “Biobetter” capabilities as evidenced by superior experimental results with actinium-225 labeled daratumumab when compared to unlabeled daratumumab, a [...]

Former General Mills Executive Joins Canadian Startup as Advisor

14/11/2017 - 14:00

PETERBOROUGH, Ontario, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Noblegen Inc. (“Noblegen”) — announces the appointment of distinguished industry veteran, Jim Kirkwood, as an official advisor to the Corporation. Kirkwood is a [...]

Intra-Cellular Therapies Presents Data on Mechanism of Action of Lumateperone and ITI-214 at the 2017 Society for Neuroscience (SfN) Annual Meeting

14/11/2017 - 14:00

NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission

14/11/2017 - 14:00

Santa Monica, CA, Nov. 14, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results

14/11/2017 - 14:00

Completed Successful EMA Meeting for DCCR in Prader-Willi Syndrome Continued Preparations to Begin Phase III Program Presented Positive Updated Safety and Efficacy Data from Pilot Clinical Trial of DCCR for Treatment of [...]